Trinity Biotech plc to Announce Third Quarter Fiscal Year 2018 Financial Results
October 16 2018 - 5:35AM
Conference Call Scheduled for October 23,
2018at 11:00 am EASTERN
Trinity Biotech plc (Nasdaq: TRIB), a leading developer and
manufacturer of diagnostic products for the point-of-care and
clinical laboratory markets, will report financial results for the
third quarter fiscal year 2018 on Tuesday, October 23, 2018. The
Company has scheduled a conference call for that same day, Tuesday,
October 23, 2018 at 11:00am ET (4:00pm BST) to discuss the results
of the quarter.
Interested parties can access the call by
dialing:
USA:
1-844-861-5499
International:
1-412-317-6581
Conference ID #: 10125358
A simultaneous webcast of the call can be accessed
at:https://www.webcaster4.com/Webcast/Page/1135/27864
A replay of the call can be accessed until October 30, 2018 by
dialing:
USA:
1-877-344-7529
International:
1-412-317-0088
Conference ID #: 10125358 The webcast of the call will be available
for 30 days at: https://www.webcaster4.com/Webcast/Page/1135/27864
Forward-looking statements in this release
are made pursuant to the "safe harbor" provision of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned
that such forward-looking statements involve risks and
uncertainties including, but not limited to, the results of
research and development efforts, the effect of regulation by the
United States Food and Drug Administration and other agencies, the
impact of competitive products, product development
commercialisation and technological difficulties, and other risks
detailed in the Company's periodic reports filed with the
Securities and Exchange Commission.Trinity Biotech develops,
acquires, manufactures and markets diagnostic systems, including
both reagents and instrumentation, for the point-of-care and
clinical laboratory segments of the diagnostic market. The products
are used to detect infectious diseases and to quantify the level of
Haemoglobin A1c and other chemistry parameters in serum, plasma and
whole blood. Trinity Biotech sells direct in the United States,
Germany, France and the U.K. and through a network of international
distributors and strategic partners in over 75 countries worldwide.
For further information please see the Company's website:
www.trinitybiotech.com.
ContactKevin TansleyTrinity Biotech
plc(353)-1-2769800E-mail: kevin.tansley@trinitybiotech.com
Joe Diaz, Joe Dorame and Robert BlumLytham Partners, LLCInvestor
Relations602-889-9700
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Sep 2023 to Sep 2024